AFT extends e-commerce presence into Amazon US

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand
Incorporated in New Zealand ARBN:
ARBN 609 017 969 investor.relations@aftpharm.com





11 July 2023

AFT extends e-commerce presence into Amazon US
AFT Pharmaceuticals (ASX: AFP, NZX: AFT) announces an extension of it s global e-
commerce strategy with the launch of online stores on Amazon in the US and
Australia.
The new AFT Pharmaceuticals-branded stores on the North American-facing
https://www.amazon.com/AFTPharmaceuticals
and the Australian facing
https://www.amazon.com.au/AFTPharmaceuticals sites complement and build on
AFT’s global e-commerce strategy.
This includes a Tmall site through which AFT sells into China using the cross-border e-
commerce platform https://kiwihealthbjp.tmall.hk/
, and the broad online presence
we already enjoy in Australia with our own AFT Pharm website shop https://nz-
shop.aftpharm.com/. The Australian site also supports our extensive distribution
network through pharmacies, medical practices and hospitals https://au-
shop.aftpharm.com/.
AFT has been working with Sell Global, a specialist Amazon agency, to launch on
Amazon USA and Australia. The project so far has included researching the market
opportunity, understanding the compliance requirements for imports, setting up
quality product listings and brand presence, and now advertising and promoting on
Amazon.
The US and Australian Amazon sites will initially carry AFT’s trusted portfolio of Liposomal
vitamins, but additional launches of other products are planned for the Australian
store in the coming months and the North American site after the initial launch is
satisfactorily completed.
The products, which will be available for US, Canadian, and Australian customers,
include Vitamin C LipoSachet
®
, Vitamin C LipoSachet
®
for Kids, Vitamin D LipoSachet
®
,
and Ferro (Iron) LipoSachet
®
.
AFT Pharmaceuticals Founder and Managing Director Dr Hartley Atkinson said: “The
Amazon AFT Pharmaceuticals e-commerce store aims to leverage off the existing
strong awareness of Liposomal vitamins in the US. To date this interest has mainly
centred around liposomal Vitamin C but AFT will also include both Vitamin D and Iron
forms of liposomal vitamins.
“The products offer a further growth opportunity for AFT’s i nternational business unit.
The US is the world’s largest market for nutritional supplements and is growing rapidly.
The North America dietary supplements market size was valued at over USD50 billion

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand
Incorporated in New Zealand ARBN:
ARBN 609 017 969 investor.relations@aftpharm.com

in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 5.6%
from 2021 to 2028
1
,
2
” Dr Atkinson said.
“Building our online presence is a further element of our strategy to extend AFT’s reach
around the world. It builds on the strong growth we are seeing in the Australasian
business, which is being fuelled by growth from existing products and a planned 68
new product launches through until the end of FY26.
“Our ecommerce presence enhances our brand recognitions in key markets enabling
us to make our products readily accessible to consumers globally.
“We also see further potential to expand our online presence. Notably, in China we
are also working to further build and evolve our existing on-line cross border e-
commerce presence through both additional products and e-commerce platforms.
“These growth initiatives will also be supported by products emerging from our
extensive research and development pipeline.”
We have also expanded our operational hubs in Singapore and Malaysia to include
Hong Kong and the United Kingdom. This will allow us to add selected products from
our new and existing Australasian pipeline to these additional markets” Dr Atkinson
said.
Released for and on behalf of AFT Pharmaceuticals limited by Malcolm Tubby, Chief
Financial Officer.

For more information:
Investors Media
Dr Hartley Atkinson Richard Inder
Managing Director The Project
AFT Pharmaceuticals Tel: +64 21 645 643
Tel: +64 9488 0232

About AFT Pharmaceuticals (ASX:AFP, NZX:AFT)
www.aftpharm.com

AFT Pharmaceuticals are a growing multinational pharmaceutical company that
develops, markets, and distributes a broad portfolio of pharmaceutical products
across a wide range of therapeutic categories which are distributed across all major
pharmaceutical distribution channels: over the counter, prescription, and hospital.
AFT Pharmaceutical's product portfolio comprises both proprietary and in -licensed
products, and includes patented, branded, and generic drugs.

About Sell Global
Sell Global - www.gosellglobal.com
Sell Global is Australasia’s leading Amazon and eMarketplace agency. Having
worked with over 300 brands to help them sell globally via Amazon and on other

1
https://www.grandviewresearch.com/industry-analysis/north-america-dietary-supplements-market
2
https://www.ibisworld.com/united-states/market-research-reports/online-vitamin-supplement-sales-industry/

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand
Incorporated in New Zealand ARBN:
ARBN 609 017 969 investor.relations@aftpharm.com

leading marketplaces like eBay and Catch, Sell Global has a unique perspective and
expertise to help brands make the best decisions and maximise their sales results.
Utilising cutting edge AI technology and data analytics, Sell Global helps brands
understand the competitive landscape for their brand and provide clarity on how
they can best compete to win. Then, with the collective experience and skills of our
full service agency team, we treat clients as partners to build sustainable success on
Amazon and eMarketplaces.